Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-24-273301
Filing Date
2024-12-09
Accepted
2024-12-09 14:35:56
Documents
4
Period of Report
2024-12-09

Document Format Files

Seq Description Document Type Size
1 6-K d919683d6k.htm 6-K 11402
2 EX-99.1 d919683dex991.htm EX-99.1 17858
3 GRAPHIC g919683g1209220255700.jpg GRAPHIC 2713
4 GRAPHIC g919683g1209220255816.jpg GRAPHIC 631
  Complete submission text file 0001193125-24-273301.txt   35259
Mailing Address 2015 PEEL STREET 5TH FLOOR MONTREAL A8 H3A 1T8
Business Address 2015 PEEL STREET 5TH FLOOR MONTREAL A8 H3A 1T8 514-336-7800
Theratechnologies Inc. (Filer) CIK: 0001512717 (see all company filings)

EIN.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1130
Type: 6-K | Act: 34 | File No.: 001-35203 | Film No.: 241534796
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)